Cargando…
Doxorubicin-Loaded Multivesicular Liposomes (DepoFoam) as a Sustained Release Carrier Intended for Locoregional Delivery in Cancer Treatment: Development, Characterization, and Cytotoxicity Evaluation
BACKGROUND: Despite the advantages of direct intratumoral (IT) injection, the relatively rapid withdrawal of most anti-cancer drugs from the tumor due to their small molecular size limits the effectiveness of this method of administration. To address these limitations, recently, increasing attention...
Autores principales: | Mahjoub, Mohammad Ali, Dadashzadeh, Simin, Haeri, Azadeh, Shahhosseini, Soraya, Abbasian, Zahra, Nowroozi, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Brieflands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990514/ https://www.ncbi.nlm.nih.gov/pubmed/36896322 http://dx.doi.org/10.5812/ijpr-134190 |
Ejemplares similares
-
Multivesicular Liposome (Depofoam) in Human Diseases
por: Salehi, Bahare, et al.
Publicado: (2020) -
Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison
por: Richard, Brigitte M., et al.
Publicado: (2011) -
An Investigation into the Role of P-Glycoprotein in the Intestinal Absorption of Repaglinide: Assessed by Everted Gut Sac and Caco-2 Cell Line
por: Yaghoobian, Morteza, et al.
Publicado: (2019) -
Preparation, In-Vitro Characterization and Pharmacokinetic Evaluation of Brij Decorated Doxorubicin Liposomes as a Potential Nanocarrier for Cancer Therapy
por: Fazel, Mohammadtaghi, et al.
Publicado: (2018) -
State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy
por: Heidarli, Elmira, et al.
Publicado: (2017)